Non-invasive method for detecting the presence of a right-to-left cardiac shunt (i.e., PFO) to enable medical treatment and/or closure before the occurrence of a debilitating or life-threatening stroke or heart attack
Start Trial Get Full Profile
There’s no risk. Start your trial today to see profiles of CardiOx plus 4771 other startups.
